Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Scilex Holding Co

CIK 1820190 SCLX·Biological Products · All EDGAR filings ↗

Progression

  1. Going concern 10-K
  2. SEC comment letter CORRESP +82d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

SEC comment letter Filing comparison

Scilex Holding Co responded to SEC staff comments on revenue recognition

Letter dated 2025-08-29; published on EDGAR 2026-07-01 — the SEC releases comment letters only after the review closes.

Please explain how legal settlement gains of $9.4 million reported in the consolidated statement of operations and comprehensive loss related to settlement agreements completed in 2024. Revise your disclosure accordingly. Response: The Company respectfully acknowledges the Staff’s comment and advises the Staff that the disclosure provided under the caption “Former Employee Action” discloses that the Company received…
Evidence
Direction
company to staff
Letter dated
2025-08-29
Published on edgar
2026-07-01
Reviewing
Scilex Holding Company Form 10-K for the Fiscal Year Ended December 31, 2024 Filed March 31, 2025 Form 10-Q for the Quarterly Period Ended June 30, 2025 Filed A
Source
Company response to SEC staff (CORRESP)
Topics
Revenue recognition, Inventory, Going concern, Fair value, MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.

Source filing ↗

SEC comment letter Filing comparison

SEC staff questioned Scilex Holding Co's accounting for MD&A

Letter dated 2025-08-20; published on EDGAR 2026-07-01 — the SEC releases comment letters only after the review closes.

Please explain how legal settlement gains of $9.4 million reported in the consolidated statement of operations and comprehensive loss related to settlement agreements completed in 2024. Revise your disclosure accordingly. Form 10-Q for the Quarterly Period Ended June 30, 2025 Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations for the Six Months Ended June 30…
Evidence
Direction
staff to company
Letter dated
2025-08-20
Published on edgar
2026-07-01
Reviewing
Scilex Holding Company Form 10-K for the Fiscal Year Ended December 31, 2024 Filed March 31, 2025 Form 10-Q for the Quarterly Period Ended June 30, 2025 Filed A
Source
SEC staff comment letter (UPLOAD)
Topics
Revenue recognition, Going concern, MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.

Source filing ↗

Late filing Filing comparison

Scilex Holding Co told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

Scilex Holding Company (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the prescribed due date, because it requires more time to finalize its financial statements to be included in such Form 10-Q, including the consolidation of Vivasor Holding Company. The Company is working diligently to complete the Form 10-Q as soon as practicable, which the Company anticipates will not be later than the fifth calendar day following the prescribed due date for the Form 10-Q, or May 20, 2026.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
Scilex Holding Company (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the prescribed due date, because it requires more time to finalize its financial statements to be included in such Form 10-Q, including the consolidation of Vivasor Holding Company. The Company is working diligently to complete the Form 10-Q as soon as practicable, which the Company anticipates will not be later than the fifth calendar day following the prescribed due date for the Form 10-Q, or May 20, 2026.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Going concern Filing comparison

Scilex Holding Co disclosed substantial doubt about its ability to continue as a going concern

No going-concern disclosure → Substantial doubt about ability to continue as a going concern

Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Basis for Opinion…
Evidence
Blank check
No
Comparable
Yes
Current state
substantial_doubt
Current state label
Substantial doubt about ability to continue as a going concern
Direction
escalated
Located in
going-concern note
Prior filed
2025-04-29
Prior form
10-K/A
Prior state
none
Prior state label
No going-concern disclosure
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.

Source filing ↗ Prior filing ↗

Accounting standard newly cited Filing comparison

Scilex Holding Co cited accounting standard ASU 2020-06 for the first time in this filing series

Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06.
Evidence
Adopted
2020-06
Contexts
Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06.
New standards
2020-06, 2023-08, 2023-09, 2024-03, 2024-04, 2025-05
Prior filed
2025-04-29
Prior form
10-K/A
Restates existing policy
No
Source
accounting standards update (ASU) reference comparison
Why
An accounting standard (ASU) appears in this filing that did not appear in the previous comparable one, in a sentence describing it as adopted. That is a change in what the company discloses, which is not always a change of policy in the current period: the filing may state an adoption date years earlier.

Source filing ↗ Prior filing ↗

Late filing elevated Filing comparison

Scilex Holding Co told the SEC it could not file its annual report on time

Does not expect a significant change in results. 1 day past the statutory due date.

Scilex Holding Company (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Form 10-K”) by March 31, 2026, the prescribed due date, because it requires more time to finalize its financial statements to be included in such Form 10-K, including the consolidation of Vivasor Holding Company. The Company is working diligently to complete the Form 10-K as soon as practicable, which the Company anticipates will not be later than the fifteenth calendar day following the prescribed due date for the Form 10-K, or April 15, 2026.
Evidence
Anticipates significant change
No
Days past due date
1
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
Scilex Holding Company (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Form 10-K”) by March 31, 2026, the prescribed due date, because it requires more time to finalize its financial statements to be included in such Form 10-K, including the consolidation of Vivasor Holding Company. The Company is working diligently to complete the Form 10-K as soon as practicable, which the Company anticipates will not be later than the fifteenth calendar day following the prescribed due date for the Form 10-K, or April 15, 2026.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗